Table 1 Clinicopathological characteristics of esophageal squamous cell carcinoma patients
From: Untargeted metabolomics analysis of esophageal squamous cell cancer progression
Characteristics | Esophageal squamous cell carcinoma TNM Stage | ||||
|---|---|---|---|---|---|
TNM Stage I (N = 15) | TNM Stage II (N = 15) | TNM Stage III (N = 15) | TNM Stage IV (N = 15) | Adjacent cancerous tissues (N = 15) | |
Age | |||||
 < 65—no. (%) | 6 (40.0) | 5 (33.3) | 9 (60.0) | 7 (46.7) | 11 (73.3) |
 ≥ 65—no. (%) | 9 (60.0) | 10 (66.7) | 6 (40.0) | 8 (53.3) | 4 (26.7) |
Genders | |||||
 Female—no. (%) | 3 (20.0) | 4 (26.7) | 1 (6.7) | 2 (13.3) | 5 (33.3) |
 Male—no. (%) | 12 (80.0) | 11 (73.3) | 14 (93.3) | 13 (86.7) | 10 (66.7) |
Body-mass index | |||||
 Median (IQR) | 20.8 (19.3–22.5) | 20.3 (18.2–22.4) | 19.2 (18.2–20.6) | 18.6(17.6–19.2) | 21.3 (19.9–23.2) |
Tumor locationa | |||||
 Lt—no. (%) | 3 (20.0) | 5 (33.3) | 9 (60.0) | 6 (40.0) |  |
 Mt—no. (%) | 10 (66.7) | 7 (46.7) | 5 (33.3) | 7 (46.7) |  |
 Ut—no. (%) | 2 (13.3) | 3 (20.0) | 1 (6.7) | 2 (13.3) |  |